首页> 美国卫生研究院文献>Pharmaceutics >Current Advances in the Development of Diagnostic Tests Based on Aptamers in Parasitology: A Systematic Review
【2h】

Current Advances in the Development of Diagnostic Tests Based on Aptamers in Parasitology: A Systematic Review

机译:基于寄生虫学中适体的诊断试验的目的进展:系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aptamers are single-stranded DNA or RNA sequences of 20–80 nucleotides that interact with different targets such as: proteins, ions, viruses, or toxins, through non-covalent interactions and their unique three-dimensional conformation. They are obtained in vitro by the systematic evolution of ligands by exponential enrichment (SELEX). Because of their ability of target recognition with high specificity and affinity, aptamers are usually compared to antibodies. However, they present many advantages that make them promising molecules for the development of new methods for the diagnosis and treatment of human diseases. In medical parasitology, aptamers also represent an attractive alternative for the implementation of new parasite detection methods, easy to apply in endemic regions. The aim of this study was to describe the current advances in the development of diagnostic tests based on aptamers in parasitology. For this, articles were selected following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, with specific inclusion and exclusion criteria. The 26 resulting articles deal with the use of aptamers for the detection of six important protozoa that affect human health. This systematic review clearly demonstrates the specificity, sensitivity and selectivity of aptamers and aptasensors, that certainly will soon become standard methods in medical parasitology.
机译:适体是20-80个核苷酸的单链DNA或RNA序列,其与不同靶标相互作用,例如:蛋白质,离子,病毒或毒素,通过非共价相互作用及其独特的三维构象。通过指数富集(SELEX)的配体的系统演化,体外获得它们。由于它们具有高特异性和亲和力的目标识别能力,则通常与抗体进行比较。然而,它们具有许多优势,使其成为开发诊断和治疗人类疾病的新方法的有希望的分子。在医疗寄生学中,适体也代表了实施新的寄生虫检测方法的有吸引力的替代方案,易于在流行区域中施加。本研究的目的是描述基于寄生虫学中适体的诊断试验的目前的进步。为此,按照系统评价和荟萃分析(PRISMA)指南的首选报告项目,以具体的包含和排除标准进行选择。由此产生的文章处理适体的使用,以检测影响人类健康的六个重要原生动物。这种系统审查清楚地证明了适体和Aptasensors的特异性,敏感性和选择性,当然将很快成为医疗寄生虫学的标准方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号